A widely used diabetes medication, SGLT2 inhibitors, has shown a surprising benefit for cancer patients—protecting their ...

A common type of diabetes medication could help cancer patients make a better long-term recovery, according to new research ...

A common diabetes drug could significantly reduce the risk of heart failure in cancer patients, potentially enhancing ...

A common type of diabetes medication may help cancer patients ward off the risk of heart failure by 50 per cent and boost l ...

SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.

“Our data suggest SGLT2 inhibition as a safe strategy to prevent kidney stone recurrence in patients with kidney stones ,” Dr Fuster’s team concluded. Other study findings indicate the empagliflozin ...

The use of GLP-1 receptor agonists corresponded with a lower risk for depression among older adults with type 2 diabetes ...

"The findings showed that recent glucose-lowering medications proved effective across various age and sex groups.

SGLT2 inhibitors reduce the risk of kidney failure in patients with Type 2 diabetes and advanced chronic kidney disease, ...

Use of GLP-1 receptor agonists to treat type 2 diabetes is not associated with an increased risk of suicidality compared with ...

New diabetes medications are pressuring Medicare Part D financially as they drive up prescription drug costs amid rising ...